Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

David Lang; Wolfgang Haslinger; Kaveh Akbari; Mario Scala; Benedikt Hergan; Christian Asel; Andreas Horner; Romana Wass; Elmar Brehm; Bernhard Kaiser; Bernd Lamprecht

doi:10.2147/LCTT.S286228

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

David Lang^*
, Wolfgang Haslinger
, Kaveh Akbari
, Mario Scala
, Benedikt Hergan
, Christian Asel
, Andreas Horner
, Romana Wass
, Elmar Brehm
, Bernhard Kaiser
, Bernd Lamprecht

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	113-121
Seitenumfang	9
Fachzeitschrift	Lung Cancer: Targets and Therapy
Volume	11
DOIs	https://doi.org/10.2147/LCTT.S286228
Publikationsstatus	Veröffentlicht - 2020

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302075 Sonographie
303 Gesundheitswissenschaften
302013 Diagnostik in der Medizin
304 Medizinische Biotechnologie
302043 Magnetresonanztomographie (MRT)
305 Andere Humanmedizin, Gesundheitswissenschaften
302010 Computertomographie (CT)
302 Klinische Medizin
303039 Radiologietechnologie
302071 Radiologie
302070 Radiodiagnostik
301 Medizinisch-theoretische Wissenschaften, Pharmazie
302068 Pulmologie
303041 Infektiologie
302030 Innere Medizin

Zugriff auf Dokument

10.2147/LCTT.S286228

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Lang, D., Haslinger, W., Akbari, K., Scala, M., Hergan, B., Asel, C., Horner, A., Wass, R., Brehm, E., Kaiser, B., & Lamprecht, B. (2020). Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study. Lung Cancer: Targets and Therapy, 11, 113-121. https://doi.org/10.2147/LCTT.S286228

@article{03eb06326ee1437c9ac3bd00b69d7e2f,

title = "Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study",

keywords = "Carcinoembryonic antigen, CYFRA 21-1, Nivolumab, Pembrolizumab, Platinum doublet chemotherapy, RECIST",

author = "David Lang and Wolfgang Haslinger and Kaveh Akbari and Mario Scala and Benedikt Hergan and Christian Asel and Andreas Horner and Romana Wass and Elmar Brehm and Bernhard Kaiser and Bernd Lamprecht",

note = "Publisher Copyright: {\textcopyright} 2020 Lang et al.",

year = "2020",

doi = "10.2147/LCTT.S286228",

language = "English",

volume = "11",

pages = "113--121",

journal = "Lung Cancer: Targets and Therapy",

issn = "1179-2728",

}

Lang, D, Haslinger, W, Akbari, K, Scala, M, Hergan, B, Asel, C, Horner, A , Wass, R , Brehm, E, Kaiser, B & Lamprecht, B 2020, 'Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study', Lung Cancer: Targets and Therapy, Jg. 11, S. 113-121. https://doi.org/10.2147/LCTT.S286228

TY - JOUR

T1 - Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

AU - Lang, David

AU - Haslinger, Wolfgang

AU - Akbari, Kaveh

AU - Scala, Mario

AU - Hergan, Benedikt

AU - Asel, Christian

AU - Horner, Andreas

AU - Wass, Romana

AU - Brehm, Elmar

AU - Kaiser, Bernhard

AU - Lamprecht, Bernd

PY - 2020

Y1 - 2020

KW - Carcinoembryonic antigen

KW - CYFRA 21-1

KW - Nivolumab

KW - Pembrolizumab

KW - Platinum doublet chemotherapy

KW - RECIST

UR - https://www.scopus.com/pages/publications/85100999784

U2 - 10.2147/LCTT.S286228

DO - 10.2147/LCTT.S286228

M3 - Article

AN - SCOPUS:85100999784

SN - 1179-2728

VL - 11

SP - 113

EP - 121

JO - Lung Cancer: Targets and Therapy

JF - Lung Cancer: Targets and Therapy

ER -